Universidad Peruana Cayetano Heredia

Comment on: Favipiravir, an antiviral for COVID-19?

Mostrar el registro sencillo del ítem

dc.contributor.author Chachaima-Mar, Jorge
dc.contributor.author Pérez-Castilla, Jesús
dc.date.accessioned 2021-04-13T20:51:02Z
dc.date.available 2021-04-13T20:51:02Z
dc.date.issued 2020
dc.identifier.uri https://hdl.handle.net/20.500.12866/9188
dc.description.abstract We have read with interest the letter by Coomes and Haghbayan, which presents favipiravir as a potential treatment for COVID-19. The authors, based on the results of in vitro studies and benefit shown in a clinical trial of this drug, state that there is an urgent need for more clinical studies of favipiravir. However, the authors only praise the results of the clinical trial of favipiravir, but they do not give information about the methodological flaws of the study. In our opinion, it is important to present the strengths and limitations of the body of evidence to readers. That is why in this letter we present some methodological aspects of this clinical trial that should be considered when interpreting the results... en_US
dc.language.iso eng
dc.publisher Oxford University Press
dc.relation.ispartofseries Journal of Antimicrobial Chemotherapy
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Humans en_US
dc.subject Pandemics en_US
dc.subject SARS-CoV-2 en_US
dc.subject COVID-19 en_US
dc.subject Antiviral Agents/therapeutic use en_US
dc.subject Amides en_US
dc.subject Pyrazines en_US
dc.title Comment on: Favipiravir, an antiviral for COVID-19? en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1093/jac/dkaa378
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.03.08
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.01.05
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#1.06.01
dc.relation.issn 1460-2091


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas